FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1036-1040 October 4, 2001 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Type 1 diabetes results from an immune-mediated destruction of pancreatic beta cells. The disease can be transmitted by bone marrow transplantation in humans¹ and animals.^2,3 Furthermore, T cells that are reactive to several islet autoantigens have been identified in both mice and humans.^4,5 Although it is generally accepted that T cells have a role during the disease process, the possible role of B cells and autoantibodies in type 1 diabetes in humans has not been fully resolved. When they are activated, B cells can produce autoantibodies to pancreatic beta-cell antigens — such as glutamic acid decarboxylase 65 (GAD65), insulin, or . . . [Full Text of this Article]

Case Report

Methods

Autoantibody Analyses

T-Cell Proliferation

Flow Cytometry

Cytokine Analyses

DNA Sequencing

Results

Characterization of Immunodeficiency

Characterization of Diabetes

Discussion

Source Information

From the German Diabetes Center, German Diabetes Research Institute, Heinrich Heine University, Düsseldorf, Germany (S.M., W.A.S., H.K.); the Children's Hospital, Hospital Minden, Minden, Germany (D.W.-E.); the Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands (G.D., B.O.R.); and the Department of Immunology, Erasmus University, Rotterdam, the Netherlands (J.G.N.).

Address reprint requests to Dr. Martin at the German Diabetes Center, German Diabetes Research Institute, Heinrich Heine University Düsseldorf, Auf'm Hennekamp 65, 40225 Düsseldorf, Germany, or at martin@dfi.uni-duesseldorf.de.

References

This article has been cited by other articles:

• Pescovitz, M. D., Greenbaum, C. J., Krause-Steinrauf, H., Becker, D. J., Gitelman, S. E., Goland, R., Gottlieb, P. A., Marks, J. B., McGee, P. F., Moran, A. M., Raskin, P., Rodriguez, H., Schatz, D. A., Wherrett, D., Wilson, D. M., Lachin, J. M., Skyler, J. S., the Type 1 Diabetes TrialNet Anti-CD20 Study Group, (2009). Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function. NEJM 361: 2143-2152 [Abstract] [Full Text]  
• Bresson, D., von Herrath, M. (2009). Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside. Diabetes Care 32: 1753-1768 [Full Text]  
• Hilbrands, R., Huurman, V. A.L., Gillard, P., Velthuis, J. H.L., De Waele, M., Mathieu, C., Kaufman, L., Pipeleers-Marichal, M., Ling, Z., Movahedi, B., Jacobs-Tulleneers-Thevissen, D., Monbaliu, D., Ysebaert, D., Gorus, F. K., Roep, B. O., Pipeleers, D. G., Keymeulen, B. (2009). Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients. Diabetes 58: 2267-2276 [Abstract] [Full Text]  
• Toma, A., Laika, T., Haddouk, S., Luce, S., Briand, J.-P., Camoin, L., Connan, F., Lambert, M., Caillat-Zucman, S., Carel, J.-C., Muller, S., Choppin, J., Lemonnier, F., Boitard, C. (2009). Recognition of Human Proinsulin Leader Sequence by Class I-Restricted T-Cells in HLA-A*0201 Transgenic Mice and in Human Type 1 Diabetes. Diabetes 58: 394-402 [Abstract] [Full Text]  
• Oak, S., Gilliam, L. K., Landin-Olsson, M., Torn, C., Kockum, I., Pennington, C. R., Rowley, M. J., Christie, M. R., Banga, J. P., Hampe, C. S. (2008). The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc. Natl. Acad. Sci. USA 105: 5471-5476 [Abstract] [Full Text]  
• Brodie, G. M., Wallberg, M., Santamaria, P., Wong, F. S., Green, E. A. (2008). B-Cells Promote Intra-Islet CD8+ Cytotoxic T-Cell Survival to Enhance Type 1 Diabetes. Diabetes 57: 909-917 [Abstract] [Full Text]  
• Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., Hutton, J. C. (2007). The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. USA 104: 17040-17045 [Abstract] [Full Text]  
• Blancou, P., Mallone, R., Martinuzzi, E., Severe, S., Pogu, S., Novelli, G., Bruno, G., Charbonnel, B., Dolz, M., Chaillous, L., van Endert, P., Bach, J.-M. (2007). Immunization of HLA Class I Transgenic Mice Identifies Autoantigenic Epitopes Eliciting Dominant Responses in Type 1 Diabetes Patients. J. Immunol. 178: 7458-7466 [Abstract] [Full Text]  
• Mallone, R., Martinuzzi, E., Blancou, P., Novelli, G., Afonso, G., Dolz, M., Bruno, G., Chaillous, L., Chatenoud, L., Bach, J.-M., van Endert, P. (2007). CD8+ T-Cell Responses Identify {beta}-Cell Autoimmunity in Human Type 1 Diabetes. Diabetes 56: 613-621 [Abstract] [Full Text]  
• Silveira, P. A., Chapman, H. D., Stolp, J., Johnson, E., Cox, S. L., Hunter, K., Wicker, L. S., Serreze, D. V. (2006). Genes within the Idd5 and Idd9/11 Diabetes Susceptibility Loci Affect the Pathogenic Activity of B Cells in Nonobese Diabetic Mice. J. Immunol. 177: 7033-7041 [Abstract] [Full Text]  
• Ivakine, E. A., Gulban, O. M., Mortin-Toth, S. M., Wankiewicz, E., Scott, C., Spurrell, D., Canty, A., Danska, J. S. (2006). Molecular genetic analysis of the idd4 locus implicates the IFN response in type 1 diabetes susceptibility in nonobese diabetic mice.. J. Immunol. 176: 2976-2990 [Abstract] [Full Text]  
• Toma, A., Haddouk, S., Briand, J.-P., Camoin, L., Gahery, H., Connan, F., Dubois-Laforgue, D., Caillat-Zucman, S., Guillet, J.-G., Carel, J.-C., Muller, S., Choppin, J., Boitard, C. (2005). Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc. Natl. Acad. Sci. USA 102: 10581-10586 [Abstract] [Full Text]  
• Moore, D. J., Noorchashm, H., Lin, T. H., Greeley, S. A., Naji, A. (2005). NOD B-cells Are Insufficient to Incite T-Cell-Mediated Anti-islet Autoimmunity. Diabetes 54: 2019-2025 [Abstract] [Full Text]  
• Acevedo-Suarez, C. A., Hulbert, C., Woodward, E. J., Thomas, J. W. (2005). Uncoupling of Anergy from Developmental Arrest in Anti-Insulin B Cells Supports the Development of Autoimmune Diabetes. J. Immunol. 174: 827-833 [Abstract] [Full Text]  
• Treszl, A., Szereday, L., Doria, A., King, G. L., Orban, T. (2004). Elevated C-Reactive Protein Levels Do Not Correspond to Autoimmunity in Type 1 Diabetes. Diabetes Care 27: 2769-2770 [Full Text]  
• Ng, Y.-S., Wardemann, H., Chelnis, J., Cunningham-Rundles, C., Meffre, E. (2004). Bruton's Tyrosine Kinase Is Essential for Human B Cell Tolerance. JEM 200: 927-934 [Abstract] [Full Text]  
• Matos, M., Park, R., Mathis, D., Benoist, C. (2004). Progression to Islet Destruction in a Cyclophosphamide-Induced Transgenic Model: A Microarray Overview. Diabetes 53: 2310-2321 [Abstract] [Full Text]  
• Silveira, P. A., Dombrowsky, J., Johnson, E., Chapman, H. D., Nemazee, D., Serreze, D. V. (2004). B Cell Selection Defects Underlie the Development of Diabetogenic APCs in Nonobese Diabetic Mice. J. Immunol. 172: 5086-5094 [Abstract] [Full Text]  
• Dromey, J. A., Weenink, S. M., Peters, G. H., Endl, J., Tighe, P. J., Todd, I., Christie, M. R. (2004). Mapping of Epitopes for Autoantibodies to the Type 1 Diabetes Autoantigen IA-2 by Peptide Phage Display and Molecular Modeling: Overlap of Antibody and T Cell Determinants. J. Immunol. 172: 4084-4090 [Abstract] [Full Text]  
• Devendra, D., Liu, E., Eisenbarth, G. S (2004). Type 1 diabetes: recent developments. BMJ 328: 750-754 [Full Text]  
• Lowe, W. L. Jr. (2003). "The Matrix Unloaded": Implications for Cytokine Signaling in Islets?. Endocrinology 144: 4262-4263 [Full Text]  
• Westerlund-Karlsson, A., Suonpaa, K., Ankelo, M., Ilonen, J., Knip, M., Hinkkanen, A. E. (2003). Detection of Autoantibodies to Protein Tyrosine Phosphatase-like Protein IA-2 with a Novel Time-resolved Fluorimetric Assay. Clin. Chem. 49: 916-923 [Abstract] [Full Text]  
• Thomas, J. W., Kendall, P. L., Mitchell, H. G. (2002). The Natural Autoantibody Repertoire of Nonobese Diabetic Mice Is Highly Active. J. Immunol. 169: 6617-6624 [Abstract] [Full Text]  
• Jaume, J. C., Parry, S. L., Madec, A.-M., Sonderstrup, G., Baekkeskov, S. (2002). Suppressive Effect of Glutamic Acid Decarboxylase 65-Specific Autoimmune B Lymphocytes on Processing of T Cell Determinants Located Within the Antibody Epitope. J. Immunol. 169: 665-672 [Abstract] [Full Text]  
• Noorchashm, H., Greeley, S. A.W., Naji, A., Farid, N. R., Roep, B. O., Kolb, H., Martin, S. (2002). B-Cell Deficiency and Type 1 Diabetes. NEJM 346: 538-539 [Full Text]  
• McDevitt, H. (2001). Closing in on Type 1 Diabetes. NEJM 345: 1060-1061 [Full Text]